E-course: Precision imaging for monitoring treatment response in patients with bladder cancer
This e-course aims to deepen your understanding of response assessment while introducing the latest insights into cutting-edge imaging techniques. Beyond technical expertise, you will receive practical strategies to navigate the clinical implications of these innovations.
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | 1.00 |
| Duration | Approx. 60 minutes |
The management of patients with muscle-invasive bladder cancer is rapidly evolving with significant advancements in both the neoadjuvant and metastatic treatment settings. These developments have placed a growing emphasis on the role of precision imaging in monitoring treatment response.
Through the lens of two real-world clinical cases, this e-course will:
- Explore the current evidence and guidelines of using MRI and PET imaging to assess treatment response to chemotherapy or immunotherapy in muscle-invasive and metastatic bladder cancer;
- Critically evaluate the benefits, limitations, and challenges of this evolving diagnostic paradigm;
- Highlight ongoing clinical trials that shape the future of response evaluation in bladder cancer care.
This e-course will enable you to integrate state-of-the-art imaging into your clinical practice which will support improved patient outcomes in this dynamic field.
Speakers:
- L. Mertens, Amsterdam (NL)
- G. Giannarini, Udine (IT
- V. Panebianco, Rome (IT)
- M. Kriegmair, Munich (DE)
- D. Oprea-Lager, Nijmegen (NL)
- A. Van Der Heijden, Nijmegen (NL)
This e-course is brought to you in collaboration with the EAU Section of Urological Imaging (ESUI).